Patents Assigned to Allex Biopharmaceuticals, Inc.
  • Peptide-based inhibitors of HIV replication
    Patent number: 5789531
    Abstract: Described herein are oligopeptides useful to inhibit replication in virally infected individuals. In a preferred embodiment of the invention, the oligopeptide is a D-arginine nonamer having N- and C-terminal protecting groups, which, at a 3 uM concentration, exhibits greater than 95% inhibition of HIV replication, in a standard assay.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: August 4, 1998
    Assignee: Allex Biopharmaceuticals, Inc.
    Inventors: Martin Sumner-Smith, Richard W. Barnett, Lorne S. Reid, Nahum Sonenberg